Sumitomo Mitsui Trust Group
AMED

Sumitomo Mitsui Trust Group’s Amedisys AMED Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,845
Closed -$1.13M – 1154
2020
Q4 		$1.13M Hold
3,845
– – ﹤0.01% 968
2020
Q3 		$909K Sell
3,845
-1,551
-29% -$353K ﹤0.01% 977
2020
Q2 		$1.07M Buy
+5,396
New +$1.01M ﹤0.01% 954
2019
Q2 		– Sell
-4,079
Closed -$503K – 1009
2019
Q1 		$503K Sell
4,079
-1,760
-30% -$221K ﹤0.01% 903
2018
Q4 		$670K Buy
+5,839
New +$688K ﹤0.01% 845

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group's AMED Position: Q1 2021 in Review

Sumitomo Mitsui Trust Group sold out of Amedisys (AMED) in Q1 2021, closing a stake of 3,845 shares — an estimated $1.13M sold.

Sumitomo Mitsui Trust Group first reported a position in AMED in Q4 2018 and held it in 5 quarters. The position peaked at $1.13M in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Sumitomo Mitsui Trust Group reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 3,845 Amedisys shares in Q1 2021, an estimated $1.13M.
  • Sumitomo Mitsui Trust Group first reported a position in Amedisys in Q4 2018 and held it in 5 quarters.
  • Sumitomo Mitsui Trust Group's Amedisys position peaked at $1.13M in Q4 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2021, filed 30 Apr 2021.